z-logo
open-access-imgOpen Access
Hypercoagulability in COVID-19: from an unknown beginning to future therapies
Author(s) -
Ștefania-Teodora Duca,
Alexandru Dan Costache,
Radu-Ștefan Miftode,
Ovidiu Mitu,
Antoniu-Octavian Petriș,
IrinaIuliana Costache
Publication year - 2022
Publication title -
medicine and pharmacy reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.35
H-Index - 16
eISSN - 2668-0572
pISSN - 2602-0807
DOI - 10.15386/mpr-2195
Subject(s) - coagulopathy , medicine , fibrinolysis , cytokine storm , fibrinogen , thrombosis , intensive care medicine , pulmonary embolism , coronavirus , sepsis , endothelial activation , fibrin , deep vein , immunology , covid-19 , inflammation , disease , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom